Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TANDEM DIABETES CARE INCTNDM · Entity 4682 | EVP & CHIEF FINANCIAL OFFICER | August 15, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TANDEM DIABETES CARE INC
Report date August 15, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 52,040 |
Ending reported balance
After 2026-08-15 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-08-15 · Exercise / conversion · Acquired 1,496 · Balance 50,895 Row 2 · 2026-08-15 · Tax withholding · Disposed 537 · Balance 50,358 F1: Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold. Row 3 · 2026-08-15 · Exercise / conversion · Acquired 2,624 · Balance 52,982 Row 4 · 2026-08-15 · Tax withholding · Disposed 942 · Balance 52,040 F1: Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 4,486 |
Reported balance
After 2026-08-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-08-15 · Exercise / conversion · Disposed 1,496 · Balance 4,486 F3: Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F4: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F5: One-third of the RSUs granted on May 23, 2024 vested on May 15, 2025, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 18,368 |
Reported balance
After 2026-08-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-08-15 · Exercise / conversion · Disposed 2,624 · Balance 18,368 F6: Awarded on May 30, 2025 pursuant to the 2023 Plan. F4: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F7: One-third of the RSUs granted on May 30, 2025 vested on May 15, 2026, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan. |
| Common StockSEC Table I · non-derivative | IndirectLeigh A. Vosseller Trust | 25,580 |
Reported balance
Holding disclosure · report date 2026-08-15 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 25,580 F2: The securities are held by the Leigh A. Vosseller Trust dated January 17, 2010, of which Leigh Vosseller is the Trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold.
F2: The securities are held by the Leigh A. Vosseller Trust dated January 17, 2010, of which Leigh Vosseller is the Trustee.
F3: Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
F4: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
F5: One-third of the RSUs granted on May 23, 2024 vested on May 15, 2025, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.
F6: Awarded on May 30, 2025 pursuant to the 2023 Plan.
F7: One-third of the RSUs granted on May 30, 2025 vested on May 15, 2026, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2024 Filed Feb 29, 2024 22:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 142 | $27.34 | $3,882.28 |
DisclosureSEC source: 0001438133-24-000036 · wk-form4_1709244773.xml · nonDerivative · entry 2 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,940 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 22:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000036 · wk-form4_1709244773.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 475 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000014 · wk-form4_1708475226.xml · derivative · entry 7 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,371 Underlying: Common Stock · 475 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F7 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. F7 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 163 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000014 · wk-form4_1708475226.xml · derivative · entry 6 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 812 Underlying: Common Stock · 163 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 195 | $24.29 | $4,736.55 |
DisclosureSEC source: 0001438133-24-000014 · wk-form4_1708475226.xml · nonDerivative · entry 4 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,675 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 475 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000014 · wk-form4_1708475226.xml · nonDerivative · entry 3 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 67 | $24.29 | $1,627.43 |
DisclosureSEC source: 0001438133-24-000014 · wk-form4_1708475226.xml · nonDerivative · entry 2 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,395 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 00:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 163 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000014 · wk-form4_1708475226.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:08 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000243 · wk-form4_1701292086.xml · derivative · entry 4 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 813 Underlying: Common Stock · 406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:08 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 141 | $19.47 | $2,745.27 |
DisclosureSEC source: 0001438133-23-000243 · wk-form4_1701292086.xml · nonDerivative · entry 2 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,299 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 21:08 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000243 · wk-form4_1701292086.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:10 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 474 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000228 · wk-form4_1700255401.xml · derivative · entry 8 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,846 Underlying: Common Stock · 474 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F8 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F8 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:10 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000228 · wk-form4_1700255401.xml · derivative · entry 7 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 975 Underlying: Common Stock · 162 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F5 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F6 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F6 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:10 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 164 | $18.20 | $2,984.80 |
DisclosureSEC source: 0001438133-23-000228 · wk-form4_1700255401.xml · nonDerivative · entry 5 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,034 F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:10 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 474 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000228 · wk-form4_1700255401.xml · nonDerivative · entry 4 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:10 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 57 | $18.20 | $1,037.40 |
DisclosureSEC source: 0001438133-23-000228 · wk-form4_1700255401.xml · nonDerivative · entry 3 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,724 F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:10 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000228 · wk-form4_1700255401.xml · nonDerivative · entry 2 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:10 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantCommon Stock | 1 | $15.47 | $15.47 |
DisclosureSEC source: 0001438133-23-000228 · wk-form4_1700255401.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,619 F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of May 16, 2023 through November 15, 2023. This transaction is also exempt under Rule 16b-3(c). Read SEC document |
| November 08, 2023 Filed Nov 13, 2023 21:32 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | PurchaseCommon Stock | 6,200 | $15.39 | $95,395.06 |
DisclosureSEC source: 0001438133-23-000214 · wk-form4_1699911153.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Indirect · Leigh A. Vosseller Trust Disclosed balance after: 11,860 F1 · price: This transaction was executed in multiple trades at prices ranging from $15.36 to $15.40 per share. The reported price reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: The securities are held by the Leigh A. Vosseller Trust dated January 17, 2010, of which Leigh Vosseller is the Trustee. Read SEC document |
| August 28, 2023 Filed Aug 30, 2023 20:19 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000192 · wk-form4_1693426755.xml · derivative · entry 4 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,219 Underlying: Common Stock · 407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| August 28, 2023 Filed Aug 30, 2023 20:19 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 141 | $27.06 | $3,815.46 |
DisclosureSEC source: 0001438133-23-000192 · wk-form4_1693426755.xml · nonDerivative · entry 2 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,618 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 28, 2023 Filed Aug 30, 2023 20:19 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000192 · wk-form4_1693426755.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 20:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 474 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000166 · wk-form4_1692303820.xml · derivative · entry 7 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,320 Underlying: Common Stock · 474 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan, as amended, and the agreements related thereto. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F7 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F7 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 20:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000166 · wk-form4_1692303820.xml · derivative · entry 6 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,137 Underlying: Common Stock · 162 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan) F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 20:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 164 | $28.88 | $4,736.32 |
DisclosureSEC source: 0001438133-23-000166 · wk-form4_1692303820.xml · nonDerivative · entry 4 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,352 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 20:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 474 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000166 · wk-form4_1692303820.xml · nonDerivative · entry 3 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,516 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 20:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 57 | $28.88 | $1,646.16 |
DisclosureSEC source: 0001438133-23-000166 · wk-form4_1692303820.xml · nonDerivative · entry 2 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,042 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 20:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000166 · wk-form4_1692303820.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,099 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 30, 2023 Filed May 31, 2023 01:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000124 · wf-form4_168549620237948.xml · derivative · entry 6 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,626 Underlying: Common Stock · 406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F8 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterlyinstallments thereafter, subject to the terms of the 2013 Plan. F8 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterlyinstallments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| May 30, 2023 Filed May 31, 2023 01:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 141 | $26.57 | $3,746.37 |
DisclosureSEC source: 0001438133-23-000124 · wf-form4_168549620237948.xml · nonDerivative · entry 2 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,937 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| May 30, 2023 Filed May 31, 2023 01:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000124 · wf-form4_168549620237948.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2023 Filed May 31, 2023 01:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantPSU 2023 05 25 · Derivative | 8,883 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000124 · wf-form4_168549620237948.xml · derivative · entry 5 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,883 Underlying: Common Stock · 8,883 shares Expires not disclosed F3 · security: Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan). F6 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2025 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest. F6 · derivative.exercise_date: Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2025 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest. F6 · derivative.expiration_date: Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2025 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest. Read SEC document |
| May 25, 2023 Filed May 31, 2023 01:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRSU 2023 05 25 · Derivative | 18,037 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000124 · wf-form4_168549620237948.xml · derivative · entry 4 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,037 Underlying: Common Stock · 18,037 shares Expires not disclosed F3 · security: Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F5 · derivative.exercise_date: RSU vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. F5 · derivative.expiration_date: RSU vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Read SEC document |
| May 15, 2023 Filed May 17, 2023 22:10 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 1,897 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000081 · wf-form4_168436140977215.xml · derivative · entry 8 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,794 Underlying: Common Stock · 1,897 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F6 · derivative.exercise_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F6 · derivative.expiration_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| May 15, 2023 Filed May 17, 2023 22:10 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 163 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000081 · wf-form4_168436140977215.xml · derivative · entry 7 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,299 Underlying: Common Stock · 163 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F5 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F5 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| May 15, 2023 Filed May 17, 2023 22:10 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 656 | $32.13 | $21,077.28 |
DisclosureSEC source: 0001438133-23-000081 · wf-form4_168436140977215.xml · nonDerivative · entry 5 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,672 F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| May 15, 2023 Filed May 17, 2023 22:10 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,897 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000081 · wf-form4_168436140977215.xml · nonDerivative · entry 4 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,328 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2023 Filed May 17, 2023 22:10 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 57 | $32.13 | $1,831.41 |
DisclosureSEC source: 0001438133-23-000081 · wf-form4_168436140977215.xml · nonDerivative · entry 3 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,431 F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| May 15, 2023 Filed May 17, 2023 22:10 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 163 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000081 · wf-form4_168436140977215.xml · nonDerivative · entry 2 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,488 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2023 Filed May 17, 2023 22:10 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantCommon Stock | 633 | $27.32 | $17,293.56 |
DisclosureSEC source: 0001438133-23-000081 · wf-form4_168436140977215.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,325 F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 16, 2022 through May 15, 2023. This transaction is also exempt under Rule 16b-3(c). Read SEC document |
| May 12, 2023 Filed May 16, 2023 23:52 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | PurchaseCommon Stock | 3,015 | $32.77 | $98,805.47 |
DisclosureSEC source: 0001438133-23-000070 · wf-form4_168428115683623.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Indirect · Leigh A. Vosseller Trust Disclosed balance after: 5,660 F1 · ownership.nature: The securities are held by the Leigh A. Vosseller Trust dated January 17, 2010, of which Leigh Vosseller is the Trustee. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 23:41 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000048 · wf-form4_167771407609190.xml · derivative · entry 4 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,032 Underlying: Common Stock · 407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F5 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 23:41 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 166 | $35.87 | $5,954.42 |
DisclosureSEC source: 0001438133-23-000048 · wf-form4_167771407609190.xml · nonDerivative · entry 2 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,692 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 23:41 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000048 · wf-form4_167771407609190.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 22:18 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000024 · wf-form4_167667230513501.xml · derivative · entry 4 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,462 Underlying: Common Stock · 162 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F5 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 22:18 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 67 | $43.11 | $2,888.37 |
DisclosureSEC source: 0001438133-23-000024 · wf-form4_167667230513501.xml · nonDerivative · entry 2 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,451 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 22:18 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000024 · wf-form4_167667230513501.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 28, 2022 Filed Nov 30, 2022 21:46 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000253 · wf-form4_166984474715299.xml · derivative · entry 4 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,439 Underlying: Common Stock · 406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F5 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| November 28, 2022 Filed Nov 30, 2022 21:46 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 141 | $39.54 | $5,575.14 |
DisclosureSEC source: 0001438133-22-000253 · wf-form4_166984474715299.xml · nonDerivative · entry 2 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,356 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| November 28, 2022 Filed Nov 30, 2022 21:46 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000253 · wf-form4_166984474715299.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.